Day 2 – Friday, January 20, 2017

8:30 – 9:00
Jim Musser, Houston Methodist Research Institute
Harnessing the Power of Whole Genome Sequencing to Investigate Host-pathogen Interactions
9:00 – 9:30
Yousif Shamoo, Rice University
Predicting Antibiotic Resistance: Moving from Reaction to Preemption of Emerging Pathogens
9:30 – 9:45
Selected Abstract for Oral Presentation
9:45 – 10:15
Break
Session 6. Convener: Yousif Shamoo
10:15 – 10:45
Robert Britton, Baylor College of Medicine
Manipulating the Microbiome to Prevent Resistance
10:45 – 11:15
Mike Lorenz, UTHealth Science Center at Houston
Inhibition of Fungal Biofilm Formation and Virulence by a Gram-positive Bacteriocin
11:15 – 11:30
Selected abstract for oral presentation
11:30 – 1:00
Poster session and lunch
Epidemiology of Antimicrobial Resistance and Clinical Impact
Session 7. Convener: Ashok Chopra and Lynn Zechiedrich
1:00 – 1:30
Vance Fowler, Duke University
Clinical Research on Staphylococcus Aureus: A Model to Tackle Multidrug-resistant Organisms
1:30 – 2:00
Maria V. Villegas, CIDEIM
The KPC Epidemic in South America
2:00 – 2:30
Sam Shelburne, MD Anderson Cancer Center
Antibiotic Resistance in Cancer Patients: The Perfect Storm
2:30 – 3:00
Cesar A. Arias, UTHealth Science Center at Houston
The MRSA USA300 Latin American Variant Epidemic
3:00 – 3:30
Break
3:30 – 4:00
Clayton Huntley, NIAID
NIH Funding Opportunities for Antimicrobial Research
4:00 – 5:00
Closing Key Note and Keck Lecture
Eric Pamer, Memorial Sloan Kettering Cancer Center
Interplay between the Microbiome and Resistant Bugs in Cancer Patients
5:00
Closing reception